Discharge pharmacotherapy for Type 2 diabetic inpatients at two hospitals of different tiers in Zhejiang Province, China

scientific article published on 08 April 2020

Discharge pharmacotherapy for Type 2 diabetic inpatients at two hospitals of different tiers in Zhejiang Province, China is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0230123
P932PMC publication ID7141672
P698PubMed publication ID32267843

P50authorXiaofang YuQ61313642
Long ZhangQ91727998
P2093author name stringSaifei Zhang
Jiao Yang
Rongbin Yu
P2860cites workThe influence of cognition on self-management of type 2 diabetes in older peopleQ26768341
Emerging epidemic of type 2 diabetes in youthQ33638822
Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China.Q34004485
Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetesQ34392352
Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimensQ34722959
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesQ35226427
β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East AsiansQ35572729
Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 DiabetesQ36073434
Incidence and time trends of type 2 diabetes mellitus in youth aged 5-19 years: a population-based registry in Zhejiang, China, 2007 to 2013.Q36318801
Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-HospitalizationQ36712203
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusQ37141727
Prevalence of Pre-Diabetes and Its Associated Risk Factors in Rural Areas of Ningbo, China.Q37203001
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 peopleQ37278100
Standards of care for type 2 diabetes in China.Q37412792
Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetesQ37577162
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.Q37652799
Glycaemic responses to glucose and rice in people of Chinese and European ethnicityQ38062578
Effect of ethnicity on glycaemic index: a systematic review and meta-analysisQ38545984
Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Q38568342
Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.Q39648063
Prevalence and control of diabetes in Chinese adultsQ40134909
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline Characteristics.Q40740553
The dirty dozen of diabetesQ41858733
Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in DiabetesQ43756580
Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patientsQ44730780
Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulationQ46178935
14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2018.Q49988570
Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes--the HOSMIDIA study.Q51030898
Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study.Q53596291
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Q56979722
Patterns and trends in insulin initiation and intensification among patients with type 2 diabetes mellitus in the Western Pacific regionQ57163149
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice GuidelineQ57245230
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)Q80358416
Diabetes prevention and continuing health-care reform in ChinaQ86547791
Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trialQ87806794
Improving the quality of insulin prescribing for people with diabetes being discharged from hospitalQ90117608
Indicator performance after the implementation of the Spanish Consensus Document for the control of hyperglycemia in the hospital and at dischargeQ90514182
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019Q90595525
The Association Between Insulin Initiation and Adverse Outcomes After Hospital Discharge in Older Adults: a Population-Based Cohort StudyQ91524990
Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UKQ93119965
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P304page(s)e0230123
P577publication date2020-04-08
P1433published inPLOS OneQ564954
P1476titleDischarge pharmacotherapy for Type 2 diabetic inpatients at two hospitals of different tiers in Zhejiang Province, China
P478volume15

Search more.